Unknown

Dataset Information

0

Data-Independent Acquisition and Parallel Reaction Monitoring Mass Spectrometry Identification of Serum Biomarkers for Ovarian Cancer.


ABSTRACT: A data-independent acquisition (DIA)/parallel reaction monitoring (PRM) workflow was implemented to identify improved ovarian cancer biomarkers. Data-independent acquisition on ovarian cancer versus control sera and literature searches identified 50 biomarkers and indicated that apolipoprotein A-IV (ApoA-IV) is the most significantly differentially regulated protein. Parallel reaction monitoring with Targeted Ovarian Cancer Proteome Assay validated differential ApoA-IV expression and quantified 9 other biomarkers. Random Forest (RF) analyses achieved 92.3% classification accuracy and confirmed ApoA-IV as the leading biomarker. Indeed, all samples were classified correctly with an [ApoA-IV] breakpoint. The next best biomarkers were C-reactive protein, transferrin, and transthyretin. The Targeted Ovarian Cancer Proteome Assay suggests that ApoA-IV is a more reliable biomarker than had been determined by immunological assays and it is a better biomarker than ApoA-I, which is in the OVA1 test for ovarian cancer. This research provides a PRM/RF approach together with 4 promising biomarkers to speed the development of a clinical assay for ovarian cancer.

SUBMITTER: Rauniyar N 

PROVIDER: S-EPMC5462478 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Data-Independent Acquisition and Parallel Reaction Monitoring Mass Spectrometry Identification of Serum Biomarkers for Ovarian Cancer.

Rauniyar Navin N   Peng Gang G   Lam TuKiet T TT   Zhao Hongyu H   Mor Gil G   Williams Kenneth R KR  

Biomarker insights 20170605


A data-independent acquisition (DIA)/parallel reaction monitoring (PRM) workflow was implemented to identify improved ovarian cancer biomarkers. Data-independent acquisition on ovarian cancer versus control sera and literature searches identified 50 biomarkers and indicated that apolipoprotein A-IV (ApoA-IV) is the most significantly differentially regulated protein. Parallel reaction monitoring with Targeted Ovarian Cancer Proteome Assay validated differential ApoA-IV expression and quantified  ...[more]

Similar Datasets

| MSV000080202 | MassIVE
| S-EPMC7947410 | biostudies-literature
| S-EPMC9280723 | biostudies-literature
| S-EPMC4985129 | biostudies-literature
| S-EPMC7346861 | biostudies-literature
2019-07-01 | GSE122971 | GEO
| S-EPMC9261276 | biostudies-literature
| S-EPMC6442367 | biostudies-literature
| S-EPMC7353590 | biostudies-literature
| S-EPMC5132254 | biostudies-literature